Tobias Ellinger

Tobias Ellinger

Auto-generated profile, based on publicly available information

Tobias Ellinger

Division of Molecular Neurobiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2024 in Nature
Verified
Journal Article
Open access
PDF file
LKLukas P. M. Kremer
Lukas P. M. Kremer
SCSantiago Cerrizuela
Santiago Cerrizuela
HEHadil El-Sammak
Hadil El-Sammak
MSMohammad Eid Al Shukairi
Mohammad Eid Al Shukairi
TETobias Ellinger
Tobias Ellinger
AMAna Martin-Villalba
Ana Martin-Villalba
Astrocytes are the most abundant cell type in the mammalian brain and provide structural and metabolic support to neurons, regulate synapses and become reactive after injury and disease. However, a small subset of astrocytes settles in specialized areas of the adult brain where these astrocytes instead actively generate differentiated neuronal and glial progeny and are therefore referred to as neural stem cells1–3. Common parenchymal astrocytes and quiescent neural stem cells share similar transcriptomes despite their very distinct functions4–6. Thus, how stem cell activity is molecularly encoded remains unknown. Here we examine the transcriptome, chromatin accessibility and methylome of neural stem cells and their progeny, and of astrocytes from the striatum and cortex in the healthy and ischaemic adult mouse brain. We identify distinct methylation profiles associated with either astrocyte or stem cell function. Stem cell function is mediated by methylation of astrocyte genes and demethylation of stem cell genes that are expressed later. Ischaemic injury to the brain induces gain of stemness in striatal astrocytes7. We show that this response involves reprogramming the astrocyte methylome to a stem cell methylome and is absent if the de novo methyltransferase DNMT3A is missing. Overall, we unveil DNA methylation as a promising target for regenerative medicine.

14 July 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
LKLukas Pm Kremer
Lukas Pm Kremer
SCSantiago Cerrizuela
Santiago Cerrizuela
MSMohammad Eid Al Shukairi
Mohammad Eid Al Shukairi
TETobias Ellinger
Tobias Ellinger
JSJannes Straub
Jannes Straub
AMAna Martin-Villalba
Ana Martin-Villalba
Summary: Stem cells in the adult brain are specialized astrocytes capable of generating neurons and glial cells. While neural stem cells (NSCs) and common astrocytes have clearly distinct functions, they share highly similar transcriptome profiles. How stemness is molecularly encoded is therefore unclear. Here we use single-cell NMT-seq to simultaneously characterize the transcriptome, DNA methylome and chromatin accessibility of astrocytes and the NSC lineage in the healthy and ischemic brain. Our data reveal distinct methylation profiles associated with either astrocyte or stem cell function. Stemness is conferred by methylation of astrocyte genes and demethylation of neurogenic genes that are expressed only later. Surprisingly, ischemic injury unlocks the stemness-methylome in common astrocytes enabling generation of neuroblasts. Furthermore, we show that oligodendrocytes employ Tet-mediated demethylation to regulate expression of myelin-related genes, many of which are abnormally methylated in multiple sclerosis. Overall, we show that DNA methylation is a promising target for regenerative medicine. Abstract Figure: